A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
NCT01331083
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
68
Enrollment
NETWORK
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
PX-866
Sponsor
NCIC Clinical Trials Group
Collaborators
[object Object]